474 related articles for article (PubMed ID: 19952056)
1. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.
Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R
Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.
Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
J Neuroimaging; 2015; 25(1):105-10. PubMed ID: 24325203
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study.
Weiduschat N; Mao X; Beal MF; Nirenberg MJ; Shungu DC; Henchcliffe C
Parkinsonism Relat Disord; 2014 May; 20(5):545-8. PubMed ID: 24593902
[TBL] [Abstract][Full Text] [Related]
4. Multimodal assessment of mitochondrial function in Parkinson's disease.
Payne T; Burgess T; Bradley S; Roscoe S; Sassani M; Dunning MJ; Hernandez D; Scholz S; McNeill A; Taylor R; Su L; Wilkinson I; Jenkins T; Mortiboys H; Bandmann O
Brain; 2024 Jan; 147(1):267-280. PubMed ID: 38059801
[TBL] [Abstract][Full Text] [Related]
5. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
Henchcliffe C; Shungu DC; Mao X; Huang C; Nirenberg MJ; Jenkins BG; Beal MF
Ann N Y Acad Sci; 2008 Dec; 1147():206-20. PubMed ID: 19076443
[TBL] [Abstract][Full Text] [Related]
6. Increased brain temperature in Parkinson's disease.
Rango M; Arighi A; Bonifati C; Bresolin N
Neuroreport; 2012 Feb; 23(3):129-33. PubMed ID: 22186803
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis.
Sassani M; Alix JJ; McDermott CJ; Baster K; Hoggard N; Wild JM; Mortiboys HJ; Shaw PJ; Wilkinson ID; Jenkins TM
Brain; 2020 Dec; 143(12):3603-3618. PubMed ID: 33439988
[TBL] [Abstract][Full Text] [Related]
8. Complex I deficiency in Parkinson's disease frontal cortex.
Parker WD; Parks JK; Swerdlow RH
Brain Res; 2008 Jan; 1189():215-8. PubMed ID: 18061150
[TBL] [Abstract][Full Text] [Related]
9. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases.
Hoang TQ; Bluml S; Dubowitz DJ; Moats R; Kopyov O; Jacques D; Ross BD
Neurology; 1998 Apr; 50(4):1033-40. PubMed ID: 9566391
[TBL] [Abstract][Full Text] [Related]
11. GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure.
Brockmann K; Hilker R; Pilatus U; Baudrexel S; Srulijes K; Magerkurth J; Hauser AK; Schulte C; Csoti I; Merten CD; Gasser T; Berg D; Hattingen E
Neurology; 2012 Jul; 79(3):213-20. PubMed ID: 22722629
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson's disease patients uncovers metabolic and mitochondrial bioenergetic defects.
Deus CM; Pereira SP; Cunha-Oliveira T; Pereira FB; Raimundo N; Oliveira PJ
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165615. PubMed ID: 31759069
[TBL] [Abstract][Full Text] [Related]
14. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.
Eleff SM; Barker PB; Blackband SJ; Chatham JC; Lutz NW; Johns DR; Bryan RN
Ann Neurol; 1990 Jun; 27(6):626-30. PubMed ID: 2360799
[TBL] [Abstract][Full Text] [Related]
15. [31P magnetic resonance spectroscopy(MRS) study in basal ganglia of patients with Parkinson's disease].
Kudo M; Mizuno Y; Morita H; Miyazaki M
Nihon Rinsho; 1997 Jan; 55(1):255-61. PubMed ID: 9014460
[TBL] [Abstract][Full Text] [Related]
16. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.
Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM
Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.
Stamelou M; Pilatus U; Reuss A; Magerkurth J; Eggert KM; Knake S; Ruberg M; Schade-Brittinger C; Oertel WH; Höglinger GU
J Cereb Blood Flow Metab; 2009 Apr; 29(4):861-70. PubMed ID: 19190655
[TBL] [Abstract][Full Text] [Related]
18. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study.
Cea G; Bendahan D; Manners D; Hilton-Jones D; Lodi R; Styles P; Taylor DJ
Brain; 2002 Jul; 125(Pt 7):1635-45. PubMed ID: 12077012
[TBL] [Abstract][Full Text] [Related]
19. Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer's disease.
Mlynárik V; Cacquevel M; Sun-Reimer L; Janssens S; Cudalbu C; Lei H; Schneider BL; Aebischer P; Gruetter R
J Alzheimers Dis; 2012; 31 Suppl 3():S87-99. PubMed ID: 22451319
[TBL] [Abstract][Full Text] [Related]
20. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
Ferrer I; Perez E; Dalfó E; Barrachina M
Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
